Return to pre-antibiotic era? AMR hits developing countries hardest
13 March 2015
New antibiotic agents are urgently needed to overcome the burgeoning problem of antimicrobial resistance (AMR) in infectious bacteria, but novel agents alone may not be sufficient to prevent a return to the dark days of the pre-antimicrobial era, an infectious disease specialist has warned.
Building a viable U.S. market is the next big quest for biosimilars
13 March 2015
While the FDA may have opened the biosimilar pipeline with its approval of Sandoz Inc.'s Zarxio Friday, a lot of heavy lifting has to be done before biosimilars are a viable market in the U.S.
Marinus Pharmaceuticals Provides Business Update and Reports Year End 2014 Financial Results
12 March 2015
Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative epilepsy and other neuropsychiatric therapeutics, today provided a business update and announced its financial results for the year ended December 31, 2014.
Mitigating Risk for Single-Use Assemblies in Sterile Filling
12 March 2015
Single-use technologies can offer significant benefits compared with traditional stainless-steel systems. The key driver is overall time savings. There are risks associated with single-use technologies, however, that can include product loss and questions around sterility assurance and product safety.
Behind the Scenes with Buffers
12 March 2015
The therapeutic efficacy of protein-based drugs depends in large part on their structure. Unfortunately, many proteins are highly sensitive to pH and other environmental factors and therefore are unstable unless maintained under certain conditions. To maintain a viable environment, different buffer solutions are required for nearly all downstream biopharmaceutical processing steps, including filtration, capture, and chromatography operations.
The Fierce survey: Is this a biotech bubble or a sustainable bull market?
12 March 2015
When Juno Therapeutics first approached investors with plans for an IPO, the year-old biotech was thinking of selling shares at $16 to $18 a share. The biotech wound up going public at $38 and this morning the share price is $51.
Sergey Beloborodov: Produce locally, think globally
12 March 2015
“The production strategies based only on import substitutule won’t last for long,” noted Sergey Beloborodov, the Ecexutive Director of NovaMedica at the round-table discussion “Attracting investments to pharmaceutical industry” held during the InvestRus International Conference in Moscow March 11, 2015.
Indonesia gains momentum as drug firms eye second year of phased national insurance
11 March 2015
Indonesia could be the new darling of healthcare industry investors, many of whom are already taking advantage of opportunities afforded by a new national health plan initiated at the beginning of last year.
7 CEOs Say It's About The "Bios": Biotechs, Biopharmaceuticals and Biosimilars
11 March 2015
It’s the booming “Bios” – biotechs, biopharmaceuticals and biosimilars – spurring capital expenditures and technology advancements, supply-and-demand questions and business decisions that grab the attention of our CEOs they are seeing in 2015.
Need to know which drugs are in short supply? FDA has an app for that
11 March 2015
The FDA has found it difficult to keep the total number of drug shortages from growing, but the agency figures it can at least help healthcare providers more easily track them. To do that it has released a mobile app that will allow anyone to use a smartphone to look up current shortages and discontinuations as well as shortages that have been resolved.
October 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
Federal Center for Animal Health develops 13 new veterinary vaccines
22 October 2024
Haemophilia treatment with new delivery method approved
22 October 2024
Immunotherapy treatment enhances lymphoma survival, landmark study shows
21 October 2024
The Russian Ministry of Health initiates the creation of a list of key drugs
21 October 2024